IBS vs Hyperliquid

Hyperliquid (HYPE) is 3804.0× the size of IBS (IBS) by market capitalisation. Over the past 30 days, HYPE is ahead by 45.0 percentage points (IBS -51.0% against HYPE -6.0%). Their daily returns move barely in opposite directions (correlation -0.25 across 30 shared trading days). IBS has been the more volatile of the two, at 95% annualised against HYPE's 82%.

Correlation: -0.25
Size ratio: 1 : 3804.0
Ahead over 30 days: HYPE

IBSIBS

$6.0100

24h: -0.01%
Market cap: $5.23M
Volume 24h: $370,721
Volatility (ann.): 95%

HyperliquidHYPE

$83.3100

24h: -3.47%
Market cap: $19.90B
Volume 24h: $1.44B
Volatility (ann.): 82%

IBS 0.0%Share of the two combined market caps100.0% HYPE

Performance

IBSHYPE

7 days-27.72%+4.65%HYPE
30 days-51.03%-6.04%HYPE

Correlation

-0.25over 30 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: -0.2590d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	IBS	HYPE
Max drawdown (400d)	-53.1%	-18.9%
Risk-adjusted return (90d)	-0.54	0.58

Relative strength over 90 days: HYPE outperformed IBS by 52.3% — measured on the IBS/HYPE ratio, so it holds regardless of market direction.

IBS →Hyperliquid →